Skip to main content

Print Bookmark

BioXell Shareholders Information

Cosmo pharmaceuticals owns 98,96% of BioXell

On March 4th 2010, Cosmo Pharmaceuticals announced that 98,96% of all BioXell shares had been tendered as a result of the public tender offer published by Cosmo on December 8, 2009. All conditions of the offer being met, the settlement of the offer took place on March 11, 2010.

Foreseen evolution of business

Work on BXL1H5 has been terminated.
The shares have been delisted on May 19, 2010. Information on BioXell will no longer be posted on the web site which may be closed shortly.
All shareholders are urged to get a bank statement confirming their shareholding post delisting, including the number of shares held.
A copy of this confirmation has to be sent to Cosmo Pharmaceuticals S.p.A. together with the Shareholder’s address (including e-mail address), so that henceforth direct contacts are possible.

Listing Prospectus Cosmo Put Options

Date Title
11/03/2010 Listing Prospectus Cosmo Put Options

Financial Calendar & Events

Date Title
20/11/2009 Convocation of Extraordinary General Meeting

Presentation

Date Title Format/Size Language
18 Nov 2009 Proposed acquisition of BioXell - Press / analyst conference call presentation / 296KB EN

Presentation (audio)

Date Title Format/Size Language
18 Nov 2009 Proposed acquisition of BioXell - Press / analyst conference call / 8.6MB EN
Get adobe reader

Most computers will open PDF documents automatically, but you may need to download Adobe Reader.